Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
|Videos|May 27, 2020
To Care for Our Patients, We Must Take Care of Ourselves
Author(s)Jessica A. Gold, MD, MS
Dr Jessi Gold provides quick tips for health care professionals to practice self-care during this difficult time.
Advertisement
Dr Jessi Gold provides quick tips for health care professionals to practice self-care during this difficult time.
Dr Gold is Assistant Professor of Psychiatry,
Twitter:
Advertisement
Related to this article
Single-dose DT120 ODT delivers rapid, sustained anxiety relief in phase 3 GAD trial, supporting FDA breakthrough path and NDA plans.
Yale trio-genomics study links hair-pulling and skin-picking to inherited OCD risk scores and rare DNA variants, hinting at shared brain pathways.
Advertisement
Advertisement
Trending on Psychiatric Times
1
New Adult ADHD Guidelines: What Resources Are Coming Soon
2
The Silence Between the Questions: Reflections on Adolescent Suicide Risk When Intent Is Unclear
3
New Real-World Data Supporting Cariprazine for MDD and Bipolar I Depression
4
Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD
5